These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 19542899

  • 1. Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.
    Jin J, Xu X, Wang F, Yan G, Liu J, Lu W, Li X, Tucker SJ, Zhong B, Cao Z, Wang D.
    J Thorac Oncol; 2009 Aug; 4(8):1017-21. PubMed ID: 19542899
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Second-line combination chemotherapy with docetaxel for cisplatin-pretreated refractory metastatic esophageal cancer: a preliminary report of initial experience.
    Tanaka T, Fujita H, Sueyoshi S, Tanaka Y, Sasahara H, Mori N, Nagano T, Yamana H, Shirouzu K.
    Chemotherapy; 2007 Aug; 53(6):449-53. PubMed ID: 17952006
    [Abstract] [Full Text] [Related]

  • 4. A pilot trial of docetaxel and nedaplatin in cisplatin-pretreated relapsed or refractory esophageal squamous cell cancer.
    Nakajima Y, Suzuki T, Haruki S, Ogiya K, Kawada K, Nishikage T, Nagai K, Kawano T.
    Hepatogastroenterology; 2008 Aug; 55(86-87):1631-5. PubMed ID: 19102357
    [Abstract] [Full Text] [Related]

  • 5. Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
    Yoshioka T, Sakayori M, Kato S, Chiba N, Miyazaki S, Nemoto K, Shibata H, Shimodaira H, Ohtsuka K, Kakudo Y, Sakata Y, Ishioka C.
    Int J Clin Oncol; 2006 Dec; 11(6):454-60. PubMed ID: 17180514
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer.
    Shim HJ, Cho SH, Hwang JE, Bae WK, Song SY, Cho SB, Lee WS, Joo YE, Na KJ, Chung IJ.
    Am J Clin Oncol; 2010 Dec; 33(6):624-8. PubMed ID: 20142726
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A phase 1/11 study of second-line chemotherapy with fractionated docetaxel and nedaplatin for 5-FU/cisplatin-resistant esophageal squamous cell carcinoma.
    Akutsu Y, Shuto K, Kono T, Uesato M, Hoshino I, Shiratori T, Miyazawa Y, Isozaki Y, Akanuma N, Matsubara H.
    Hepatogastroenterology; 2012 Oct; 59(119):2095-8. PubMed ID: 22328303
    [Abstract] [Full Text] [Related]

  • 10. Phase I/II study of docetaxel/cisplatin/fluorouracil combination chemotherapy against metastatic esophageal squamous cell carcinoma.
    Takahashi H, Arimura Y, Yamashita K, Okahara S, Tanuma T, Kodaira J, Hokari K, Tsukagoshi H, Shinomura Y, Hosokawa M.
    J Thorac Oncol; 2010 Jan; 5(1):122-8. PubMed ID: 19898259
    [Abstract] [Full Text] [Related]

  • 11. A phase II trial of docetaxel plus nedaplatin and 5-fluorouracil in treating advanced esophageal carcinoma.
    Guo JF, Zhang B, Wu F, Wang B, Xing H, Zhu GY, Nie XY, Peng J.
    Chin J Cancer; 2010 Mar; 29(3):321-4. PubMed ID: 20193118
    [Abstract] [Full Text] [Related]

  • 12. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
    Zhang XD, Shen L, Li J, Li Y, Li J, Zhang XT, Jin ML.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer.
    Kanekiyo S, Takeda S, Nakajima M, Nishiyama M, Kitahara M, Shindou Y, Michihisa I, Abe T, Yoshino S, Hazama S, Nagano H.
    Anticancer Res; 2016 Apr; 36(4):1923-7. PubMed ID: 27069181
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy with docetaxel and nedaplatin for recurrent esophageal cancer in an outpatient setting.
    Osaka Y, Takagi Y, Hoshino S, Tachibana S, Tsuchida A, Aoki T.
    Dis Esophagus; 2006 Apr; 19(6):473-6. PubMed ID: 17069591
    [Abstract] [Full Text] [Related]

  • 15. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus.
    Yamasaki M, Miyata H, Tanaka K, Shiraishi O, Motoori M, Peng YF, Yasuda T, Yano M, Shiozaki H, Mori M, Doki Y.
    Oncology; 2011 Apr; 80(5-6):307-13. PubMed ID: 21778771
    [Abstract] [Full Text] [Related]

  • 16. A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.
    Yamazaki K, Hironaka S, Boku N, Yasui H, Fukutomi A, Yoshino T, Onozawa Y, Hasuike N, Inui T, Yamaguchi Y, Ono H.
    Int J Clin Oncol; 2008 Apr; 13(2):150-5. PubMed ID: 18463960
    [Abstract] [Full Text] [Related]

  • 17. Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma.
    Honda M, Miura A, Izumi Y, Kato T, Ryotokuji T, Monma K, Fujiwara J, Egashira H, Nemoto T.
    Dis Esophagus; 2010 Nov; 23(8):641-5. PubMed ID: 20545978
    [Abstract] [Full Text] [Related]

  • 18. A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
    Cao W, Xu C, Lou G, Jiang J, Zhao S, Geng M, Xi W, Li H, Jin Y.
    Jpn J Clin Oncol; 2009 Sep; 39(9):582-7. PubMed ID: 19509000
    [Abstract] [Full Text] [Related]

  • 19. Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.
    Ojima T, Nakamori M, Nakamura M, Katsuda M, Hayata K, Matsumura S, Iwahashi M, Yamaue H.
    Dis Esophagus; 2017 Feb 01; 30(2):1-7. PubMed ID: 26725778
    [Abstract] [Full Text] [Related]

  • 20. A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.
    Zhang X, Shen L, Li J, Li Y, Li J, Jin M.
    Am J Clin Oncol; 2008 Feb 01; 31(1):29-33. PubMed ID: 18376224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.